Glaucoma Research Foundation is dedicated to scientific research that deepens our understanding of glaucoma, generates new treatments, and will ultimately lead to a cure. …
Glaucoma and Alzheimer’s Disease are two of the most severe age-related conditions affecting millions worldwide.
The Melza M. and Frank Theodore Barr Foundation Catalyst for a Cure Initiative to Prevent and Cure Neurodegeneration began their investigations in 2022.
The Steven and Michele Kirsch Catalyst for a Cure Vision Restoration Initiative (CFC3) is seeking innovative ways to regrow or replace retinal ganglion cells and axons, which make up the optic nerve.
Currently, there is extensive research and development on “drop-free” or “drop-less” technologies for delivering glaucoma medications to the eye.
GRF’s $50,000 grants initiate creative research ideas.
The Shaffer Prize for Innovative Glaucoma Research recognizes grant recipients whose projects best exemplify the pursuit of breakthrough ideas to better understand and cure glaucoma.
Jeffrey Goldberg, MD, PhD reviews recent research progress and explains the potential risks.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
